Assessment of peak inspiratory flow through dry powder inhalers in asthmatics

G. A. Pinheiro, V. C. S. Antao, J. M. Jansen (Rio de Janeiro, Brazil)

Source: Annual Congress 2002 - Bronchial responsiveness, nebulization, devices and airway inflammation
Session: Bronchial responsiveness, nebulization, devices and airway inflammation
Session type: Thematic Poster Session
Number: 3358
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. A. Pinheiro, V. C. S. Antao, J. M. Jansen (Rio de Janeiro, Brazil). Assessment of peak inspiratory flow through dry powder inhalers in asthmatics. Eur Respir J 2002; 20: Suppl. 38, 3358

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Peak inspiratory flow (PIF) when using a dry powder inhaler in asthmatics and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 99s
Year: 2001

Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers
Source: Eur Respir J 2001; 18: 780-783
Year: 2001



Peak inspiratory flow rates in COPD patients with Easyhaler® dry powder inhaler
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Measurement of inspiratory flow through 3 different dry powder inhalation devices using In-check in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 493s
Year: 2001

Peak inspiratory flow in COPD: implications for the use of dry powder inhalers
Source: Eur Respir J 2001; 18: Suppl. 33, 134s
Year: 2001

Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients
Source: Annual Congress 2012 - Asthma management
Year: 2012


Peak inspiratory flow rate and the slope of the inhalation profile in dry powder inhalers (DPI)
Source: Eur Respir J 2001; 18: Suppl. 33, 69s
Year: 2001

Inspiratory profiles and resistance of two dry powder inhalers in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 291s
Year: 2004

Selection of the dry powder inhaler based on peak inspiratory measurements in the preselected group of patients with bronchial obstruction
Source: Eur Respir J 2001; 18: Suppl. 33, 99s
Year: 2001

Asthmatic children generate significantly different peak inspiratory flow rates (PIFR) through two different dry powder inhalers (DPI)
Source: Eur Respir J 2003; 22: Suppl. 45, 494s
Year: 2003

Peak inspiratory flow measured at different inhaler resistances in patients with asthma
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Inspiratory profiles and consistency of behaviour regarding dose delivery characteristics of two dry powder inhalers in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 13s
Year: 2004

In vitro performance characteristics of a novel multi-dose dry powder inhaler Airmax™ at different inspiratory flow rates
Source: Eur Respir J 2002; 20: Suppl. 38, 541s
Year: 2002

Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs)
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Severe asthmatic patients generate significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI)
Source: Eur Respir J 2004; 24: Suppl. 48, 308s
Year: 2004

Assessment of inhaler technique using inspiratory flow measurement
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007


Analysis of peak inspiratory flow and use of dry powder inhalers in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019


Inspiratory flow patterns with dry powder inhalers (DPIs) of low and medium flow resistance in subjects with pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020


In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003

The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012